Published by Frank Prenesti on 14th December 2023
(Sharecast News) - Shares in Moderna surged on Thursday after trial results of its experimental cancer vaccine, used in conjunction with Merck's Keytruda treatment, reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three years.
URL: http://www.digitallook.com/dl/news/story/33973005/...